Canada, April 25, 2018 -- Zentric, Inc. (OTC: ZNTR) is pleased to announce that it intends to file audited financial statements, so that it can become a fully reporting company. Zentric, Inc. is currently in the process of shortlisting PCAOB auditing firms that can audit the company's consolidated financial statements. To the extent that Zentric, Inc. continues to grow through its subsidiaries and through its own acquisition of joint venture partner companies, the company sees the need to start becoming a fully reporting issuer, with the objective of ultimately being listed on a nationally recognized exchange once it meets certain qualifications.
FORWARD-LOOKING INFORMATION
Safe Harbor Statement:
This release may include "forward looking statements" within the meaning of Section 27 A of the Securities Act 1933 as amended, and Section 21 E and/or 27 E of the Securities Exchange Act of 1934, that are based on assumptions that in the future are inherently uncertain, may prove not to be accurate, and are subject to significant risks and uncertainties. These include but are not limited to statements as to the future performance of the company, its ability to raise necessary financing, and other general economic risks and uncertainties.
Investor Relations: Jeff Mak [email protected] www.zntr.com


Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
How Marco Pharma International Preserves German Homeopathic Traditions in America
Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation
Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy 



